Evidence map›Paper›PMID 41220913›Full record

ArticleExperimental and therapeutic medicine2026

Effect of the water-soluble matrix of nanometer pearl powder on the osteogenic differentiation of hFOB1.19 cells.

Xinghuanyu Xu, Lin Liu, Wenbai Zhang, Pu Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xinghuanyu XuDepartment of Oral Implantology, Stomatology Center, Affiliated Haikou Hospital, Xiangya Medical College, Central South University, Haikou, Hainan 570100, P.R. China.
Lin LiuDepartment of Oral Implantology, Stomatology Center, Affiliated Haikou Hospital, Xiangya Medical College, Central South University, Haikou, Hainan 570100, P.R. China.
Wenbai ZhangDepartment of Oral Implantology, Stomatology Center, Affiliated Haikou Hospital, Xiangya Medical College, Central South University, Haikou, Hainan 570100, P.R. China.
Pu XuDepartment of Oral Implantology, Stomatology Center, Affiliated Haikou Hospital, Xiangya Medical College, Central South University, Haikou, Hainan 570100, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pearl powder, especially its main effective component water-soluble matrix (WSM), can promote bone formation. The present study analyzed the effect of various WSM concentrations on the osteogenic differentiation of hFOB1.19 cells. The WSM of nanometer pearl powder (NPP) was obtained through the water extraction method. hFOB1.19 cells were then cultured with WSM at concentrations of 0, 10, 20 and 40 µg/ml. Thereafter, alkaline phosphatase (ALP) activity and alizarin red staining were analyzed to detect the effects of WSM on the osteogenic differentiation and mineralization of hFOB1.19 cells. In addition, type I collagen, osteocalcin, osteopontin and Runt-associated transcription factor 2 mRNA and protein expression levels during osteogenic differentiation were measured through reverse transcription-quantitative PCR and western blotting. Following WSM treatment, ALP activity, alizarin red staining of mineralized nodules and osteoblast-related protein expression levels were all found to be elevated in hFOB1.19 cells. In conclusion, these results suggested that NPP WSM could promote the differentiation and mineralization of hFOB1.19 cells within the tested concentration range to induce an osteogenic effect.

Indexed as

hFOB1.19 cellsnanometer pearl powderosteoblastosteogenic differentiationwater-soluble matrix

Identifiers

PMID41220913
PMCPMC12598726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.